37th Annual San Antonio Breast Cancer Symposium. Resumen de las aportaciones translacionales y clínicas más relevantes
Magazine: Revista de Senología y Patología Mamaria
Date: Mar 1, 2015Breast Cancer Area Medical Oncology
The 37th San Antonio Breast Cancer Symposium, held in December 2014, provided an opportunity to gain greater knowledge.
Notable contributions were the following:
- in basic research, the acquisition of mutations in carcinogenesis and metastasis, which increase with clonality and heterogeneity; the prognostic role of neoantigens and infiltrating lymphocytes in the residual tumor after neoadjuvant chemotherapy; and an increased knowledge of molecular mutations in the estrogen receptor, which explain hormonal resistance
- in the translational arena, the role of patient-derived xenografts to avoid therapeutic resistance; and the role of liquid biomarkers to detect minimal residual disease in early breast cancer
- in the clinical scenario, advances in prevention and hormone therapy, and news on triple-negative tumors and immunotherapy.
CITATION Revista de Senología y Patología Mamaria 03/2015; DOI: 10.1016/j.senol.2015.02.001
you maybe interested
The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.
The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.
Learn why we are different from other healthcare centers. Quality, speed, comfort and results.